NCT01596556

Brief Summary

To the best of our knowledge, a possible relation between smoking and heat injuries or heat intolerance was never scientifically examined, although such a relation is logical according to the observations that smoking has a thermogenic effect, decreases physical fitness and affects the body's heat dissipation.16 healthy young male volunteers will participate in the study, 8 smokers and 8 non-smokers. They will arrive to our lab four or six times. They will perform VO2 test and heat tolerance test (HTT) in different conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 11, 2012

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
Last Updated

May 9, 2014

Status Verified

May 1, 2014

Enrollment Period

1.5 years

First QC Date

May 6, 2012

Last Update Submit

May 8, 2014

Conditions

Keywords

smokingexerciseheat toleranceheat stroke

Outcome Measures

Primary Outcomes (2)

  • Heat tolerance

    The test is performed in a climatic chamber at a temperature of 40oC and 40% relative humidity. During the test, the subject walks on a treadmill at a speed of 5 km/hr at a 2% grade for 2h. Body core temperature and heart rate are continuously monitored, and sweat rate is computed from body weight prior to and after the test, corrected for fluid intake. Heat intolerance is determined when body core temperature elevates above 38.5oC, when heart rate elevates above 150 bpm, or when either does not tend to reach a plateau.

    2-3 days

  • VO2max

    volunteer's oxygen consumption (VO2) will be monitored continuously with a metabolic chart (ZAN), while running for 10 min on a treadmill under comfortable environmental conditions.

    2-3 days

Secondary Outcomes (2)

  • Rectal temperature

    experimental days 4,5,6

  • Heart rate

    experimental days 4,5,6

Study Arms (2)

smokers

EXPERIMENTAL

This arm consists of smokers.

Drug: NicotineOther: cigarette smoking

non-smokers

ACTIVE COMPARATOR

non-smoking participants in the study

Drug: Nicotine

Interventions

both groups will be given nicotine lozenges before a VO2 test and a HTT.

non-smokerssmokers

the smokers will smoke 2 cigarettes before a VO2 exam and a HTT.

smokers

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age 18-30
  • healthy
  • after medical checkup
  • after signing concent form
  • for the smokers: smoking 0.5-1.5 packs of cigarettes a day at least 2 years.

You may not qualify if:

  • heart disease
  • respiratory disease
  • baseline bp above 140/90 mmHg
  • diabetes
  • anhydrosis
  • skin disease
  • acute illness
  • detoxification from nicotine
  • allergy to nicotine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Institute of Military Physiology Heller Institute of Medical Research

Tel-Hashomer Ramat-Gan, Israel

Location

MeSH Terms

Conditions

Cigarette SmokingSmokingMotor ActivityHeat Stroke

Interventions

Nicotine

Condition Hierarchy (Ancestors)

Tobacco SmokingBehaviorTobacco UseHeat Stress DisordersWounds and Injuries

Intervention Hierarchy (Ancestors)

Solanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-Ring

Study Officials

  • Amit Druyan, M.D

    Sheba Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2012

First Posted

May 11, 2012

Study Start

June 1, 2012

Primary Completion

December 1, 2013

Study Completion

May 1, 2014

Last Updated

May 9, 2014

Record last verified: 2014-05

Locations